Source: Web Search Revision Year: 2019 Publisher: Astellas Pharmaceuticals A.E.B.E., 6-8 Agisilaou Str., 15123 Marousi, Athens-Greece Tel: +30 210 8189900 Fax: +30 216 8008998
Omnic 0,4, 0.4 mg, modified release capsules, hard.
Pharmaceutical Form |
---|
Modified release capsule, hard. Orange/olive-green coded 0.4 and logo and 701. |
Each capsule contains as active ingredient tamsulosin hydrochloride 0.4 mg.
Excipient(s): For a full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Tamsulosin |
Tamsulosin binds selectively and competitively to post-synaptic α1-adrenoreceptors, prevailingly their subtypes designated α1A and α1D. Thus relaxation of smooth muscles of the prostate and urethra is achieved, which leads to a reduction of tonus and an improvement of the urinary flow. |
List of Excipients |
---|
Capsule content: Microcrystalline Cellulose E460 Capsule shell: Hard gelatin |
Polypropylene-aluminium blister packs containing 10 capsules per strip; cardboard boxes containing 10, 20, 30, 50, 60, 90, 100 and 200 capsules.
PVC/PVDC-aluminium blister packs containing 5 capsules per strip: cardboard boxes containing 50 capsules.
Not all pack sizes may be marketed.
Astellas Pharmaceuticals A.E.B.E., 6-8 Agisilaou Str., 15123 Marousi, Athens-Greece
Tel: +30 210 8189900
Fax: +30 216 8008998
MA1387/00101
18th January 2006
Drug | Countries | |
---|---|---|
OMNIC | Brazil, Cyprus, Germany, Estonia, Spain, Finland, Croatia, Israel, Italy, Malta, Netherlands, Poland, Romania, Tunisia |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.